Are you working with advanced therapies in Denmark? Join us on 23 October for an afternoon focused on the development and regulation of Advanced Therapy Medicinal Products (ATMPs).
ATMPs have the potential to treat serious diseases for which few or no treatment options currently exist. At the same time, their development, manufacture, and use are complex and subject to specific regulatory requirements.
The Danish Medicines Agency therefore invites you to an ATMP Open House on Friday, 23 October, from 12:30 PM to 3:30 PM at Axel Heides Gade 1, 2300 Copenhagen S.
The event is primarily aimed at clinical and academic environments in Denmark.
Programme
Our experts will give short presentations on topics including:
- IMPD: Why is it needed, and what are the main challenges?
- Manufacturing authorisations and GMP: What is what?
- What European opportunities are available for early regulatory advice?
- What does it take to use a commercial ATMP?
- Who is ATMP Denmark?
After the presentations, we will host a mini-fair where you can meet our ATMP experts, ask specific questions, and receive guidance on relevant regulatory processes.
Register here
Participation is in person, and places are limited:
The event will be held in English.
If you are unable to attend, you are welcome to give your place to a colleague.
Excerpt from the official page. The original is authoritative.